GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ono Pharmaceutical Co Ltd (OTCPK:OPHLY) » Definitions » EBIT per Share

OPHLY (Ono Pharmaceutical Co) EBIT per Share : $0.59 (TTM As of Sep. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Ono Pharmaceutical Co EBIT per Share?

Ono Pharmaceutical Co's EBIT per Share for the three months ended in Sep. 2024 was $0.12. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 was $0.59.

During the past 12 months, the average EBIT per Share Growth Rate of Ono Pharmaceutical Co was -22.90% per year. During the past 3 years, the average EBIT per Share Growth Rate was 19.10% per year. During the past 5 years, the average EBIT per Share Growth Rate was 22.30% per year. During the past 10 years, the average EBIT per Share Growth Rate was 24.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Ono Pharmaceutical Co's EBIT per Share or its related term are showing as below:

OPHLY' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -26.9   Med: 0.6   Max: 61.3
Current: 19.1

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Ono Pharmaceutical Co was 61.30% per year. The lowest was -26.90% per year. And the median was 0.60% per year.

OPHLY's 3-Year EBIT Growth Rate is ranked better than
67.86% of 837 companies
in the Drug Manufacturers industry
Industry Median: 6.8 vs OPHLY: 19.10

Ono Pharmaceutical Co's EBIT for the three months ended in Sep. 2024 was $173 Mil.

Ono Pharmaceutical Co EBIT per Share Historical Data

The historical data trend for Ono Pharmaceutical Co's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ono Pharmaceutical Co EBIT per Share Chart

Ono Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EBIT per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.50 0.62 0.60 0.74 0.76

Ono Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.27 0.24 0.08 0.15 0.12

Ono Pharmaceutical Co EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Ono Pharmaceutical Co's EBIT per Share for the fiscal year that ended in Mar. 2024 is calculated as

EBIT per Share(A: Mar. 2024 )
=EBIT/Shares Outstanding (Diluted Average)
=1094.41/1440.261
=0.76

Ono Pharmaceutical Co's EBIT per Share for the quarter that ended in Sep. 2024 is calculated as

EBIT per Share(Q: Sep. 2024 )
=EBIT/Shares Outstanding (Diluted Average)
=173.301/1409.190
=0.12

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ono Pharmaceutical Co  (OTCPK:OPHLY) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Ono Pharmaceutical Co EBIT per Share Related Terms

Thank you for viewing the detailed overview of Ono Pharmaceutical Co's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Ono Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ono Pharmaceutical Co Ltd (OTCPK:OPHLY) » Definitions » EBIT per Share
Comparable Companies
TSE:4151 TSE:4536 TSE:4552 TSE:4882 TSE:4578 TSE:4503 LLY JNJ MRK ABBV XSWX:ROG LSE:AZN XSWX:NOVN PFE AMGN XPAR:SAN BMY GILD LSE:GSK TSE:4568
Traded in Other Exchanges
OPHLF:USA 4528:Japan ON4:Germany
Address
8-2, Kyutaromachi 1-chome, Chuo-ku, Osaka, JPN, 541-8564
Website
http://www.ono.co.jp
Ono Pharmaceutical Co Ltd is a drug manufacturer with a focus on drug discovery in areas of unmet medical needs. It maintains a world-wide business in specialty pharmaceuticals. The company breaks out its revenue of goods and products into eight segments. The vast majority of Ono's revenue is derived from its circulatory and respiratory drugs, followed by its metabolic drugs and vitamins. The company also reports revenue derived from royalties. The bulk of Ono's sales are generated in Japan, followed by the rest of Asia and Europe.